StonvexLoading…
StonvexStonvexStonvexCore line items from GS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $58.28B | $53.51B | $46.25B | $47.37B |
Operating Income | $21.85B | $18.40B | $10.74B | $13.49B |
Net Income | $17.18B | $14.28B | $8.52B | $11.26B |
EPS (Diluted) | $51.32 | $40.54 | $22.87 | $30.06 |
Total Assets | $1.81T | $1.68T | $1.64T | $1.44T |
Total Liabilities | $1.68T | $1.55T | $1.52T | $1.32T |
Cash & Equivalents | $164.26B | $182.09B | $241.58B | $241.82B |
Free Cash Flow OCF − CapEx | $-47.22B | $-15.30B | $-14.90B | $4.96B |
Shares Outstanding | 296.48M | 310.65M | 323.38M | 334.92M |